flufenamic acid   Click here for help

GtoPdb Ligand ID: 2447

Approved drug PDB Ligand Immunopharmacology Ligand
flufenamic acid is an approved drug
Compound class: Synthetic organic
Comment: A non-selective cyclooxygenase inhibitor; NSAID.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 49.33
Molecular weight 281.07
XLogP 4.2
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Isomeric SMILES OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
InChI InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)
1. Chen XZ, Vassilev PM, Basora N, Peng JB, Nomura H, Segal Y, Brown EM, Reeders ST, Hediger MA, Zhou J. (1999)
Polycystin-L is a calcium-regulated cation channel permeable to calcium ions.
Nature, 401 (6751): 383-6. [PMID:10517637]
2. Dai L, Garg V, Sanguinetti MC. (2010)
Activation of Slo2.1 channels by niflumic acid.
J Gen Physiol, 135 (3): 275-95. [PMID:20176855]
3. Di Pizio A, Waterloo LAW, Brox R, Löber S, Weikert D, Behrens M, Gmeiner P, Niv MY. (2020)
Rational design of agonists for bitter taste receptor TAS2R14: from modeling to bench and back.
Cell Mol Life Sci, 77 (3): 531-542. [PMID:31236627]
4. Garg P, Sanguinetti MC. (2012)
Structure-activity relationship of fenamates as Slo2.1 channel activators.
Mol Pharmacol, 82 (5): 795-802. [PMID:22851714]
5. Hill K, Benham CD, McNulty S, Randall AD. (2004)
Flufenamic acid is a pH-dependent antagonist of TRPM2 channels.
Neuropharmacology, 47 (3): 450-60. [PMID:15275834]
6. Hu H, Tian J, Zhu Y, Wang C, Xiao R, Herz JM, Wood JD, Zhu MX. (2010)
Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs.
Pflugers Arch, 459 (4): 579-92. [PMID:19888597]
7. Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S. (1998)
Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity.
J Biochem, 124 (5): 940-6. [PMID:9792917]
8. Skarydová L, Zivná L, Xiong G, Maser E, Wsól V. (2009)
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
Chem Biol Interact, 178 (1-3): 138-44. [PMID:19007764]
9. Togashi K, Inada H, Tominaga M. (2008)
Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB).
Br J Pharmacol, 153 (6): 1324-30. [PMID:18204483]
10. Ullrich ND, Voets T, Prenen J, Vennekens R, Talavera K, Droogmans G, Nilius B. (2005)
Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice.
Cell Calcium, 37 (3): 267-78. [PMID:15670874]